Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Alcohol consumption, genetic variants in the alcohol- and folate metabolic pathways and colorectal cancer risk: the JPHC Study.

Svensson T, Yamaji T, Budhathoki S, Hidaka A, Iwasaki M, Sawada N, Inoue M, Sasazuki S, Shimazu T, Tsugane S.

Sci Rep. 2016 Nov 9;6:36607. doi: 10.1038/srep36607.

2.

Lack of association between MTHFR C677T polymorphism and breast cancer risk in Ahvaz, west south-Iran.

Mohammadzadeh G, Karimi M, Bazyar M, Hosseini SM.

Adv Biomed Res. 2016 Feb 15;5:26. doi: 10.4103/2277-9175.176352. eCollection 2016.

3.

Meta-Prediction of MTHFR Gene Polymorphism Mutations and Associated Risk for Colorectal Cancer.

Shiao SP, Yu CH.

Biol Res Nurs. 2016 Jul;18(4):357-69. doi: 10.1177/1099800415628054. Epub 2016 Feb 8.

4.

Association between folate metabolism-related polymorphisms and colorectal cancer risk.

Kim JW, Jeon YJ, Jang MJ, Kim JO, Chong SY, Ko KH, Hwang SG, Oh D, Oh J, Kim NK.

Mol Clin Oncol. 2015 May;3(3):639-648. Epub 2015 Feb 27.

5.

Genetic and environmental risk assessment and colorectal cancer screening in an average-risk population: a randomized trial.

Weinberg DS, Myers RE, Keenan E, Ruth K, Sifri R, Ziring B, Ross E, Manne SL.

Ann Intern Med. 2014 Oct 21;161(8):537-45. doi: 10.7326/M14-0765.

6.

MTHFR A1298C and C677T gene polymorphisms and susceptibility to chronic myeloid leukemia in Egypt.

Aly RM, Taalab MM, Ghazy HF.

Int J Clin Exp Pathol. 2014 Apr 15;7(5):2571-8. eCollection 2014.

7.

Ethnic background and genetic variation in the evaluation of cancer risk: a systematic review.

Jing L, Su L, Ring BZ.

PLoS One. 2014 Jun 5;9(6):e97522. doi: 10.1371/journal.pone.0097522. eCollection 2014. Review.

8.
9.

Nucleotide excision repair gene polymorphisms, meat intake and colon cancer risk.

Steck SE, Butler LM, Keku T, Antwi S, Galanko J, Sandler RS, Hu JJ.

Mutat Res. 2014 Apr;762:24-31. doi: 10.1016/j.mrfmmm.2014.02.004. Epub 2014 Mar 7.

10.

The 677C>T (rs1801133) polymorphism in the MTHFR gene contributes to colorectal cancer risk: a meta-analysis based on 71 research studies.

Teng Z, Wang L, Cai S, Yu P, Wang J, Gong J, Liu Y.

PLoS One. 2013;8(2):e55332. doi: 10.1371/journal.pone.0055332. Epub 2013 Feb 20.

11.

Folate Intake, MTHFR Polymorphisms, and the Risk of Colorectal Cancer: A Systematic Review and Meta-Analysis.

Kennedy DA, Stern SJ, Matok I, Moretti ME, Sarkar M, Adams-Webber T, Koren G.

J Cancer Epidemiol. 2012;2012:952508. doi: 10.1155/2012/952508. Epub 2012 Oct 18.

12.

Associations between Intake of Folate, Methionine, and Vitamins B-12, B-6 and Prostate Cancer Risk in American Veterans.

Vidal AC, Grant DJ, Williams CD, Masko E, Allott EH, Shuler K, McPhail M, Gaines A, Calloway E, Gerber L, Chi JT, Freedland SJ, Hoyo C.

J Cancer Epidemiol. 2012;2012:957467. doi: 10.1155/2012/957467. Epub 2012 Aug 9.

13.

The polymorphisms in methylenetetrahydrofolate reductase, methionine synthase, methionine synthase reductase, and the risk of colorectal cancer.

Zhou D, Mei Q, Luo H, Tang B, Yu P.

Int J Biol Sci. 2012;8(6):819-30. doi: 10.7150/ijbs.4462. Epub 2012 Jun 8.

14.

Genetic variants in IGF-I, IGF-II, IGFBP-3, and adiponectin genes and colon cancer risk in African Americans and Whites.

Keku TO, Vidal A, Oliver S, Hoyo C, Hall IJ, Omofoye O, McDoom M, Worley K, Galanko J, Sandler RS, Millikan R.

Cancer Causes Control. 2012 Jul;23(7):1127-38. doi: 10.1007/s10552-012-9981-2. Epub 2012 May 8.

15.

Haplotype analysis of the 5,10-methylenetetrahydrofolate reductase (MTHFR) c.1298A>C (E429A) polymorphism.

Semmler A, Moskau S, Lutz H, Meyer P, Linnebank M.

BMC Res Notes. 2011 Oct 24;4:439. doi: 10.1186/1756-0500-4-439.

16.

Hematopoietic prostaglandin D synthase (HPGDS): a high stability, Val187Ile isoenzyme common among African Americans and its relationship to risk for colorectal cancer.

Tippin BL, Levine AJ, Materi AM, Song WL, Keku TO, Goodman JE, Sansbury LB, Das S, Dai A, Kwong AM, Lin AM, Lin JM, Park JM, Patterson RE, Chlebowski RT, Garavito RM, Inoue T, Cho W, Lawson JA, Kapoor S, Kolonel LN, Le Marchand L, Haile RW, Sandler RS, Lin HJ.

Prostaglandins Other Lipid Mediat. 2012 Jan;97(1-2):22-8. doi: 10.1016/j.prostaglandins.2011.07.006. Epub 2011 Jul 28.

17.

Genetics, cytogenetics, and epigenetics of colorectal cancer.

Migliore L, Migheli F, Spisni R, Coppedè F.

J Biomed Biotechnol. 2011;2011:792362. doi: 10.1155/2011/792362. Epub 2011 Feb 14. Review.

18.

Variation in folate pathway genes and distal colorectal adenoma risk: a sigmoidoscopy-based case-control study.

Levine AJ, Lee W, Figueiredo JC, Conti DV, Vandenberg DJ, Davis BD, Edlund CK, Henning SM, Heber D, Stern MC, Haile RW.

Cancer Causes Control. 2011 Apr;22(4):541-52. doi: 10.1007/s10552-011-9726-7. Epub 2011 Jan 28.

19.

A randomized trial of genetic and environmental risk assessment (GERA) for colorectal cancer risk in primary care: trial design and baseline findings.

Myers RE, Manne SL, Wilfond B, Sifri R, Ziring B, Wolf TA, Cocroft J, Ueland A, Petrich A, Swan H, DiCarlo M, Weinberg DS.

Contemp Clin Trials. 2011 Jan;32(1):25-31. doi: 10.1016/j.cct.2010.08.013. Epub 2010 Sep 7.

20.

MTHFR polymorphisms in relation to ovarian cancer risk.

Terry KL, Tworoger SS, Goode EL, Gates MA, Titus-Ernstoff L, Kelemen LE, Sellers TA, Hankinson SE, Cramer DW.

Gynecol Oncol. 2010 Nov;119(2):319-24. doi: 10.1016/j.ygyno.2010.08.007.

Supplemental Content

Support Center